Tobramycin Cefazolin

Other antimicrobial agents that have been incorporated into PMMA beads and shown to have useful elution profiles include penicillin G (ben-zylpenicillin), ampicillin, amoxicillin, flucloxacillin, amoxiciUin-clavulanate, cefamandole, cefazolin, tobramycin, netilmicin, imipenem, erythromycin, ciprofloxacin, trimethoprim-sulfamethoxazole, chloramphenicol and vancomycin (Ethell et al 2000, Mader et al 1997, Veyries et al 2000). 

In ophthalmology, both trans-scleral and transcomeal dmg delivery has been studied. Drags investigated include fluorescein, tobramycin, gentamicin, ticarcillin, cefazolin, dexamethasone and ketoconazole. Iontophoresis has been found to be both safe and effective in delivering the required doses locally, at the intended site of action. Excepting for lidocaine, which has been tested in human volunteers, all the other drags have been tested in rabbits. 

Aminoglycosides are poorly absorbed from the gastrointestinal tract, so when used systemically they must be given parenterally. Note that penicillins or cephalosporins can inactivate aminoglycosides if mixed together in the same solution fiar injection or fiar topical application each drug must be administered separately. If topical fortified cefazolin and fortified tobramycin are used to treat a corneal ulcer, each should be prepared and administered in a separate bottle. 

Treatment of microbial keratitis is started immediately irrespective of whether microbiologic evaluation has been performed. The best antimicrobial agent or agents to use initially is debated in the ophthalmic literature. The two main choices for initial antibiotic treatment are the combination of two fortified antibiotics, such as cefazolin and tobramycin, or monotherapy with topical fluoroquinolones. Just as with the decision to culture, the choice of antibiotic is often influenced by history and clinical presentation. Milder presentations, in low-risk... 

Manley HJ, Bailie GR, Frye R, Hess LD, McGoldrick MD. Pharmacokinetics of intermittent intravenous cefazolin and tobramycin in patients treated with automated peritoneal dialysis. J Am Soc Nephrol 2000 11(7) 1310-16. 

The final component of the dialysis prescription that may affect drug clearance by dialysis is whether or not the patient has anthorized the unit to reuse his or her dialyzer. Currently, more than 75% of all dialysis units in the United States use this procedure to reduce the cost of chronic hemodialysis. The effect of dialysis filter reuse on the clearance of endogenous molecules such as urea, creatinine, and P2-microglobulin has been evaluated for many dialyzers. A decrease in urea and creatinine clearances and an increase in /S2-mictoglobulin clearance was observed with some, but not all, dialyzers. Only one center has evaluated the effect of reuse on drug clearance (cefazolin, ceftazidime, tobramycin, and vancomycin) following the first and tenth use of cellulose acetate, cellulose triacetate, and polysulfone... 

Gentamicin or tobramycin or neomycin-gramicidin/polymyxin B, cefazolin... 

Extracted cefamandole, cefazolin, cefoxitin, cephapirin, chloramphenicol Simultaneous acetaminophen, N-acetylprocainamide, cefaclor, cephalexin, cephalothin, ci-metidine, miconazole, moxalactam, procainamide, sulfamethoxazole, theophylline, tobramycin, vancomycin... 

Noninterfering acetaminophen, N-acetylprocainamide, amikacin, amitriptyline, ampicil-lin, carbamazepine, cefamandole, cefazolin, cefoperazone, cefotaxime, cefoxitin, ceftazidime, ceftizoxime, cephalexin, cephalothin, cephapirin, chloramphenicol, ciprofloxacin, clonazepam, (yclosporine, desipramine, digoxin, disopyramide, ethosuximide, gentamicin, haloperidol, imipramine, kanamycin, lidocaine, mezlocillin, netilmicin, nortriptyline, phenobarbital, phenytoin, primidone, procainamide, propranolol, quinidine, salicylic acid, streptomycin, sulfamethoxazole, theophylline, thiamphenicol, ticarcillin, tobramycin, trimethoprim, vancomycin... 

Noninterfering amikadn, carbenicillin, cefazolin, cefoperazine, cefoxitin, chloramphenicol, ciprofloxacin, gentamicin, imipenem, moxalactam, oxacillin, ticeircillin, tobramycin, vancomycin... 

Noninterfering acetaminophen, acyclovir, allopurinol, amoxicillin, amphotericin B, am-picillin, aspirin, azlocillin, bendrofluazide, bumetanide, buprenorphine, carbenidllin, cefazolin, cefotaxime, cefoxitin, ceftazidime, cefuroxime, cephalexin, chlorambucil, chloramphenicol, chlordiazepoxide, chlorpheniramine, chlorpropamide, cyclophosphamide, cyclosporin, C5d arabine, daunorubicin, dextropropoxyphene, dihydrocodeine, domperidone, flucytosine, furosemide, gentamicin, griseofulvin, melphalan, methotrexate, metochlo-pramide, metronidazole, miconazole, nabilone, netilmicin, nicotinamide, nitrazepam, penicillin G, piperacillin, prednisolone, procarbeizine, prochlorperazine, riboflavin, rifampin, sulfamethoxazole, thioguanine, tobramycin, tolbutamide, trimethoprim... 

Another study assessing the risk factors for nephrotoxicity with aminoglycosides (tobramycin and gentamicin) enrolled 1489 patients, 157 of whom developed clinical nephrotoxicity. Of these patients 118 had no immediately identifiable cause (such as acute renal failure) and further evaluation of other risk factors found that the concurrent use of cephalosporins (including cefazolin, cefotaxime, cefoxitin, cefamandole, ce-furoxime, ceftriaxone, and ceftazidime) significantly increased the risk of nephrotoxicity. ... 

---